Form 4 ·Enliven Therapeutics, Inc.
Accession 0001701247-26-000012 Issuer CIK 0001672619 As filed ELVN
Period of report 2026-08-17 · Filed 2026-08-19 · Accepted 2026-08-19 16:16 UTC
The lines as filed
Every stored line in txn_seq order, exactly as the filing reports them. Each row has its own anchor, so a single line is citable.
| Direction | Line | Date | Owner | Code | Security | Shares | Price | Value USD | Held after |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2026-08-17 |
Collins Helen Louise Officer (CHIEF MEDICAL OFFICER) |
S, Open-market sale | Common Stock | 3,900 disposed | 58.37 | 227,649.63 | 26,100 | |
| 2 | 2026-08-17 |
Collins Helen Louise Officer (CHIEF MEDICAL OFFICER) |
S, Open-market sale | Common Stock | 1,100 disposed | 59.35 | 65,281.15 | 25,000 |
This column is intentionally blank
This filing is stored with no transaction line. Where the parse status above says failed or partial, that is the reason; the primary document on EDGAR is authoritative.
- S, Open-market sale
- Open-market sale
Values are shares multiplied by the reported price, computed by the store's own generated column and never estimated. A line whose filing reported no price has no value and says so.
Reporting owners
One entry per owner named on this filing, each anchored so a single owner block is citable. Multi-owner filings are real, and this block is why the catalog never misattributes them.
Provenance
Where this row came from, when it was retrieved, and what the parser made of it.
- Primary document
- https://www.sec.gov/Archives/edgar/data/1672619/0001701247-26-000012-index.htm
- Accepted by EDGAR
- 2026-08-19 16:16 UTC
- Retrieved by ebomi
- 2026-08-20 05:22 UTC
Other filings for the same period
Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.
How to cite this page
ebomi catalog. Form 4 0001701247-26-000012. Retrieved 2026-08-20 from https://ebomi.com/filing/0001701247-26-000012
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6
US Securities and Exchange Commission. Form 4, accession 0001701247-26-000012. The filing on EDGAR